Daniela Cipolletta
Seminars
Thursday 10th December 2026
Engineering Next-Generation Biologics to Enhance Selectivity, Durability & Clinical Impact in Complement Therapeutics
11:00 am
- Developing novel biologics, including bispecific antibodies, fusion proteins and engineered complement regulators, to improve therapeutic performance
- Optimizing pharmacokinetics, tissue targeting and mechanism of action to enhance efficacy while minimizing treatment burden
- Leveraging advances in protein engineering to create differentiated therapies across complement-mediated diseases
NEW SPEAKING COMPANY
